CorMedix to report Q1 2026 financial results and hold update call on May 14

CorMedix Therapeutics will announce its financial results for the first quarter ending March 31, 2026, before market open on May 14, 2026. The company will also host a corporate update conference call at 8:30 AM Eastern Time on the same day. CorMedix focuses on developing and marketing therapeutic products for serious diseases in the U.S., particularly in institutional healthcare settings. This update follows recent positive clinical trial results, highlighting the company's ongoing progress.